The New Leader in Incontinence Control
PMD is an evolving medical device company dedicated to pioneering the development of new medical devices that will, prospectively, be used to treat a wide range of chronic diseases and disorders. Since its inception in 1998, PMD has brought together a number of outstanding medical professionals and engineers to complete the design and development work on the Company’s initial line of products. We continue to expand the inventory of proprietary technology we have created and patented. The engineering projects PMD is currently undertaking include new devices that treat chronic conditions such as:
- Urinary Incontinence
- Fecal Incontinence
- Erectile Dysfunction
- GERDs (Gastro-esophageal Reflux Disease)
PMD has been directing its R&D efforts toward the first use of its Flow Control Device (FCD) technology for the treatment of severe urinary incontinence (UI). Although UI affects up to an estimated 500 million people worldwide, the severest cases are responsible for the greatest portion of the costs, which are estimated around $50 billion or more, in the US alone and up to $500 billion worldwide annually.
Beyond the expenses, the true cost is measured in a pervasive and widespread loss of productivity and quality-of-life for many of those afflicted and for those who are caretakers of the afflicted. Severe UI has a devastating effect on a wide range of sufferers, from children with neurogenic bladder disorders like Spina Bifida, to women who have simply undergone childbirth resulting in vaginal prolapse, to people who have contracted debilitating diseases such as Muscular Dystrophy and Multiple Sclerosis, the elderly who have dementia and Alzheimer’s (UI being the primary cause of nursing home admissions), and to many of those people who have been the unfortunate recipient of a spinal cord injuries.
Although there currently exists a broad array of UI treatments in the market that range from simple exercise routines, to non-invasive devices, to drugs, and all the way up to invasive surgery and surgically implanted devices, none of the current treatments have been found to be universally effective, nor universally accepted as a definitive cure across the whole range of incontinence sufferers, especially for those suffering from severe UI. Due to the ineffectiveness of all of the current treatment products, still over 90% of all UI sufferers are “treated” with diapers or catheters.
PMD has, with the efforts of its world-class engineering team, headed by a former lead engineer for Pfizer, and under the direction of some of the world’s foremost experts in the field of urology, invented and patented a new implantable electro-mechanical device that promises to safely, and effectively treat even the most severe cases of UI. It is expected to become the new “gold standard” in the treatment of severe UI.